Nanoform Finland Oyj (STO: NANOFS)
Sweden
· Delayed Price · Currency is SEK 14.00
-0.20 (-1.41%)
At close: Dec 20, 2024
Nanoform Finland Oyj Revenue
Nanoform Finland Oyj had revenue of 774.00K EUR in the quarter ending September 30, 2024, with 20.75% growth. This brings the company's revenue in the last twelve months to 2.43M, down -23.00% year-over-year. In the year 2023, Nanoform Finland Oyj had annual revenue of 2.57M, down -26.41%.
Revenue (ttm)
2.43M EUR
Revenue Growth
-23.00%
P/S Ratio
n/a
Revenue / Employee
14.71K EUR
Employees
165
Market Cap
1.19B SEK
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.14B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Medicover AB (publ) | 22.60B |
| Vitrolife AB (publ) | 3.56B |
| Bonesupport Holding AB (publ) | 814.46M |